Efficacy and safety comparison between belotecan and topotecan in patients with recurrent or refractory ovarian cancer: A multi-center, randomized, open-labelled, parallel-group phase IIb trial.

Kim, Hee Seung; Park, Sang-Yoon; Park, Chan-Yong; Kim, Young-Tae; Kim, Beob-Jong; Song, Yong Jung; Kim, Byoung Gie; Kim, Yong Beom; Cho, Chi-Heum; Kim, Jong-Hyeok; Song, Yong Sang

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

Efficacy and safety comparison between belotecan and topotecan in patients with recurrent or refractory ovarian cancer: A multi-center, randomized, open-labelled, parallel-group phase IIb trial.

Authors: Kim, Hee Seung; Park, Sang-Yoon; Park, Chan-Yong; Kim, Young-Tae; Kim, Beob-Jong; Song, Yong Jung; Kim, Byoung Gie; Kim, Yong Beom; Cho, Chi-Heum; Kim, Jong-Hyeok; Song, Yong Sang

Issue Date: 20-May-2015

Publisher: AMER SOC CLINICAL ONCOLOGY

Citation: JOURNAL OF CLINICAL ONCOLOGY, v.33, no.15

Journal Title: JOURNAL OF CLINICAL ONCOLOGY

Volume: 33

Number: 15

URI: https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10517

DOI: 10.1200/jco.2015.33.15_suppl.5527

ISSN: 0732-183X

Files in This Item: There are no files associated with this item.

Appears in Collections: ETC > 1. Journal Articles

Show full item record

qrcode

Altmetrics

Total Views & Downloads

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Altmetrics

Total Views & Downloads

BROWSE